Dr Reddy’s: Should we look beyond impairments? Trading Calls - Equity F&O February 1, 2021Recommendations Large part of impairment charge taken by Dr Reddy’s is explained by the erosion in the value of Nuvaring due to the launch of the additional generic product by Teva Anubhav Sahu
